Given the increasing implications of Fn in periodontal diseases, preterm birth, and cancer development and chemoresistance [18–20], it can be highly desirable to further enhance and characterize the anti-Fn activities of new MOD-tsRNA variants through different chemical modifications for the following reasons. This evidence concerns the gene FN1 and cancer.